Return-Path: <apicuedxcl@hotmail.com>
Delivered-To: em-ca-bruceg@em.ca
Received: (qmail 31782 invoked by uid 115); 5 Jan 2005 07:47:59 -0000
Received: from apicuedxcl@hotmail.com by churchill by uid 64011 with qmail-scanner-1.22 
 (clamdscan: 0.75-1. spamassassin: 2.63.  Clear:RC:0(208.138.130.81):. 
 Processed in 0.47004 secs); 05 Jan 2005 07:47:59 -0000
Received: from mmp-2.gci.net (208.138.130.81)
  by churchill.factcomp.com with SMTP; 5 Jan 2005 07:47:58 -0000
Received: from mx3.hotmail.com (223-133-58-66.gci.net [66.58.133.223])
 by mmp-2.gci.net
 (iPlanet Messaging Server 5.2 HotFix 1.14 (built Mar 18 2003)) with ESMTP id
 <0I9U003A51P4DJ@mmp-2.gci.net> for bruceg@em.ca; Tue,
 04 Jan 2005 22:48:17 -0900 (AKST)
Date: Wed, 05 Jan 2005 02:47:46 -0400
From: Roland Hansen <apicuedxcl@hotmail.com>
Subject: Still Growing!
To: bruski@electrinet.com, bryan1@electrinet.com
Cc: bruceg@em.ca, brucef@foxinternet.net, brucek@foxinternet.net,
 bruhnrv@foxinternet.net
Message-id: <0I9U0033T2Z4DJ@mmp-2.gci.net>
MIME-version: 1.0
X-MIMEOLE: Produced By Microsoft MimeOLE V6.00.2900.2180
X-Mailer: Microsoft Office Outlook, Build 11.0.5510
Content-type: multipart/alternative;
 boundary="Boundary_(ID_uUXxXAPFXR4CyNgSw1rjLA)"
Thread-index: AcTotwGxFzq9hJF/Rb2KzeG6rvp1Bw==

This is a multi-part message in MIME format.

--Boundary_(ID_uUXxXAPFXR4CyNgSw1rjLA)
Content-type: text/plain; charset=us-ascii
Content-transfer-encoding: 7BIT

THIS ONE IS STILL GROWING!! GET IN NOW!

In Vivo Medical Surges on Momentum

Momentum Traders ***** IVVO up on substantial trading volume

This stock has been moving, active traders take note, IVVO up over 50% in 10
trading sessions!!!

DON'T MISS OUT ON ANOTHER DAY OF GAINS.  Massive Promotional Campaign
ongoing with additional news coming! 
We don't know what IVVO has in the works, but if the trading activity is any
indication, this company could be moving much higher in the short term.

*****************************************************

OTCBB:IVVO
SHARES OUTSTANDING         ~5,020,000 (Last 10QSB filing)
MARKET CAPITALIZATION  ~$10,542,000  -     (As of 12/17/04)

IMPRESSIVE GAINS THIS PAST WEEK IS JUST THE BEGINIING!!!!!

In Vivo Medical Diagnostics, Inc (Stock Symbol OTC: IVVO) is finalizing its
first ground-breaking portable medical device, the Prothrombin Time Monitor,
that measures changes in the magnetic fields of blood on a molecular level.
This is critical for patients undergoing anticoagulation therapy after heart
attacks and strokes. This measurement is now portable and is used in real
time to achieve optimal medication levels, which is essential for successful
treatment. IVVO has recently announced their joint effort with Inverness
Medical Innovations a leading manufacturer and marketer of rapid diagnostic
products in order to complete development of the Prothrombin Time Monitor
for its clinical trials. Prothrombin Testing is a massive market and
continues to grow with projections in excess of $150 million in 2005 and
over $500 million by 2010. IVVO is poised to capitalize on this significant
opportunity. Don't miss out on the near term upside potential in IVVO! 

 

INVESTMENT ANAYSIS 

In Vivo Medical Diagnostics, Inc. (Stock Symbol OTC: IVVO)

Short-Term Target: $3.00-$4.00

12-Month Target: $6.00-$7.00

Recommendations: Very Strong Buy

Long Term Outlook: Excellent 



The Industry

Heart disease is the most common cause of death and cardiovascular disease
affects over 60 million people worldwide. The largest area of growth in the
Health Care Sector is in Patient Management. This growth is caused by
patients with chronic conditions, who are forced to make frequent and costly
hospital visits to monitor their condition. 



WHY IVVO?

 

IVVO is a well-established company that has been operating for over eight
years. IVVO currently has two additional products in their 2nd clinical
trials, a pregnancy labor monitor and a fetal heart rate monitor, along with
12 Patents that will allow them to extend their technology to other emerging
medical solutions. IVVO is currently profitable with additional royalty
income beginning in 2005. IVVO has sufficient funds on hand to take them
well into 2006. 

 

IVVO is a momentum play with incredible short-term potential.  Risk adverse
traders take note.

 

Information within this email contains "forward looking statements" within
the meaning of Section 27A of the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, goals, expectations, beliefs,
plans, projections, objectives, assumptions or future events or performance
are not statements of historical fact and may be "forward looking
statements." Please be advised that nothing within this email shall
constitute a solicitation or an offer to buy or sell any security mentioned
herein. This newsletter is neither a registered investment advisor nor
affiliated with any broker or dealer. This newsletter is not affiliated with
In Vivo Medical Diagnostics. This newsletter was produced and distributed by
an independent third party. John Howard was compensated 7500 dollars to
express and distribute his opinion through this E-mail. All statements made
are our express opinion only and should be treated as such. We may own, buy
and sell any securities mentioned at any time. This report includes
forward-looking statements within the meaning of The Private Securities
Litigation Reform Act of 1995. These statements may include terms as
"expect", "believe", "may", "will", "move","undervalued" and "intend" or
similar terms. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY
PROFILED COMPANY. You may lose money from investing in Penny Stocks.


--Boundary_(ID_uUXxXAPFXR4CyNgSw1rjLA)
Content-type: text/html; charset=us-ascii
Content-transfer-encoding: 7BIT

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=us-ascii">
<META content="MSHTML 6.00.2900.2523" name=GENERATOR></HEAD>
<BODY>
<DIV><FONT face=Arial size=2>
<P class=MsoNormal style="MARGIN: 0in 0in 12pt"><SPAN
style="mso-bidi-font-size: 10.0pt"><FONT face="Times New Roman" size=3>TH<g>IS ONE IS STILL <v>GROWING<l>!! GET IN <x>NOW!   In Vivo<k>
Medical<j> Su<e>rges on Momentum<BR><BR>Momentum <m>Trad<f>ers
*****<l> IVVO up on su<g>bsta<c>ntial tr<h>ading volume<FONT COLOR="#FFFFFF" SIZE="1">XGNO></FONT><BR><BR>Th<t>is stock has been<l> <k>
moving, active <g>trader<w>s take note, I<l>VVO up <d>over 50% in 10<BR>tradi<l>ng
s<n>essions!!!<?xml:namespace prefix = o ns =
"urn:schemas-microsoft-com:office:office" /><o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="MARGIN: 0in 0in 12pt"><SPAN
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'; mso-bidi-font-size: 10.0pt">D<d>ON'T
MIS<c>S OUT ON ANO<r>THER DAY OF G<l>AINS.&n<x>bsp; Massive Pro<o>mot<k>ional Campaign on<w>going
<l>
wit<v>h additional <y>news coming! <FONT COLOR="#FFFFFF" SIZE="1">YV></FONT><BR>We<y> don't k<h>now what I<x>VVO has in the <g>works, but
<m>
if t<f>he trading ac<r>tivity is any<BR>indica<c>tion, this c<y>om<v>pany could be mo<h>ving<w> much
high<v>er in the short
<o>
term.<BR><FONT COLOR="#FFFFFF" SIZE="1">TCDW></FONT><BR>**<d>**************<o>*************<l>**<h>**********<r>************<BR><BR>OTCBB:IVVO<FONT COLOR="#FFFFFF" SIZE="1">SOCA></FONT><BR><x>SHARES
OUTSTAND<d>ING &nb<t>sp;&nbsp;&nbsp<f>;&n<t>bsp;&nbsp;&nbsp<h>;&nbsp<e>; ~5,020,000<SPAN
style="mso-tab-count: 1"> </SPAN><c>(Last 10QSB filing)<BR><c>MARKET
CAPITAL<k>IZATION<SPAN style="mso-spacerun: yes">&nbsp; </SPAN><c>~$10,542,000<SPAN
style="mso-spacerun: yes">&nbsp; </SPAN>-<SPAN
style="mso-spacerun: yes">&<l>nbsp;&nbsp;&n<g>bsp;&nbsp; </SPAN><t>(As of
12/17/04)<o:p></o:p></SPAN></P>
<P class=MsoNormal style="MARGIN: 0in 0in 12pt"><SPAN
style="mso-bidi-font-size: 10.0pt"><FONT size=3><FONT
face="Times New Roman">I<B>MPRESS<w>IVE GAINS THI<j>S PA<w>ST WEEK IS JUST <n>THE<e>
BEGINIING!!!!!</B><o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in; TEXT-ALIGN: justify"><FONT
face="Times New Roman" size=3>In Viv<x>o Medical Dia<e>gnostics,<o> Inc (Sto<k>ck Symbol
<r>
OTC: <B>IVVO</B>)<t> is finali<v>zing its fir<v>st ground-brea<o>king p<g>ortable <h>medical
device, <l>the <B>Prot<o>hrombin Time<t> Monitor, </B>that m<d>easures chan<n>ges in<k> the
magneti<x>c fields <o>of blood<l> on a mo<x>lecular<w> level. This is <f>critical f<j>or patie<o>nts
und<f>ergoing an<x>ticoagu<d>lation therapy <w>after he<l>art attacks an<v>d str<m>okes. This
<n>measurem<k>ent is <e>now portab<h>le and is <g>used in real time <w>to achi<j>eve opt<g>imal
med<v>ication levels,<c> which is<n> essent<o>ial for su<g>ccessful tre<n>atmen<j>t. IVVO has
rec<w>ently a<o>nnounced their<w> j<d>oint effort wi<w>th Inverness <r>Medical<e> Innova<j>tions a
lea<g>ding ma<e>nufacturer and <r>marketer<x> of rapi<n>d diagno<j>stic product<g>s in order to <l>
complete de<l>velo<t>pment of th<t>e Prothromb<r>in Time M<h>onitor for <o>its clinical<g> trials. <x>
Prot<f>hrombin Tes<v>ting is a ma<g>ssive<l> market and contin<f>ues to<g> grow w<d>ith projec<t>tions
in e<n>xcess of $1<e>50 milli<x>on in 2005<h> and over $500<o> million <d>by 2010. IVVO<g> is pois<c>ed
to ca<v>pitalize on <o>this sig<g>nificant opp<v>ortunity<y>. Don&#8217;t<w> miss out<w> on t<n>he near t<t>erm
upside pote<j>n<m>tial in IVVO! </FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in; TEXT-ALIGN: justify"><FONT
face="Times New Roman" size=3></FONT>&nbsp;</P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><B><SPAN
style="mso-bidi-font-size: 10.0pt"><FONT face="Times New Roman"
size=3>INVES<e>TMENT ANAYSIS</FONT></SPAN></B><SPAN
style="COLOR: red; mso-bidi-font-size: 10.0pt"><FONT face="Times New Roman"
size=3> <BR><FONT COLOR="#FFFFFF" SIZE="1">IMZX></FONT><BR>I<w>n Vivo Medical Di<y>agnost<e>ics, Inc. <B>(S<v>tock Sym<e>bol OTC:
IVVO)<o:p></o:p></B></FONT></FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><FONT
face="Times New Roman" size=3>Short-Ter<g>m Targe<f>t: $3.00-$4.00</FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><FONT
face="Times New Roman" size=3>12<v>-Month Targ<n>et: $6.00-$7.00</FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><FONT
face="Times New Roman" size=3>Recomm<h>endat<l>ions: Very Strong<v> Buy</FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><FONT
face="Times New Roman" size=3><m>Long Term Outl<n>ook: Excellent </FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><SPAN
style="mso-bidi-font-size: 10.0pt"><BR><BR>The Indus<w>try<FONT COLOR="#FFFFFF" SIZE="1">HRNQ></FONT><BR><BR>Heart<c> disease i<o>s the mos<g>t commo<h>n cause of deat<w>h
and c<v>ardiovascular<x> disease<v> affects over<c> 60<e> million <h>people wo<l>rldwide. T<l>he largest
area <t>of gro<f>wth in <k>the Health Care <r>Sector is <l>in Pat<g>ient Managemen<r>t. This grow<g>th
i<x>s caused by p<n>atie<y>nts with chronic <k>con<r>ditions, who ar<l>e f<r>orced to mak<d>e frequent
a<c>nd costl<l>y hospital vis<n>its to<g> monit<o>or their condition. </FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><SPAN
style="mso-bidi-font-size: 10.0pt"><SPAN
style="mso-spacerun: yes"></SPAN><BR><FONT COLOR="#FFFFFF" SIZE="1">KS></FONT><BR>WHY IVVO?<o:p></o:p></FONT></FONT></B></SPAN></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><SPAN
style="mso-bidi-font-size: 10.0pt"><FONT size=3><FONT
face="Times New Roman">&nbsp;<o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in; TEXT-ALIGN: justify"><FONT
face="Times New Roman" size=3>IVVO is<k> a well<x>-establ<d>ished company tha<f>t <j>has been
op<l>erating fo<y>r over eight y<k>ears.<h> IVVO cur<t>rently has two ad<e>diti<l>onal product<y>s in
their 2<SUP>nd</SUP> clin<m>ical tria<c>ls, a <v>pregnancy labor mo<m>nitor and <r>a fetal
<f>heart rate<y> moni<x>tor, along wit<f>h 12 Pa<c>tents <t>that will al<n>low them <t>to extend their
<y>tec<v>hnology to oth<m>er emergin<n>g medi<c>cal solutions. I<k>VVO is c<j>urrently<r> profita<t>ble
with ad<w>ditio<j>nal royalty inc<t>ome beginning <h>in 2<l>005. IVVO <r>has sufficien<c>t funds on<v>
h<c>and to take<f> them well into 20<d>06. </FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><SPAN
style="mso-bidi-font-size: 10.0pt"><o:p><FONT face="Times New Roman"
size=3>&nbsp;</FONT></o:p></SPAN></P>
<P class=MsoBodyText3 style="MARGIN: 0in 1.5in 0pt 0in"><FONT
face="Times New Roman" size=3>IVVO is a<c> moment<x>um play with <m>in<g>credible short-t<m>erm
pot<o>ential.&n<k>bsp; Ri<e>sk adverse<o> traders<x> take note.</FONT></P>
<P class=MsoNormal style="MARGIN: 0in 1.5in 0pt 0in"><SPAN
style="mso-bidi-font-size: 10.0pt"><o:p><FONT face="Times New Roman"
size=3>&nbsp;</FONT></o:p></SPAN></P>
<P class=MsoBodyText2 style="MARGIN: 0in 1.5in 0pt 0in"><FONT
face="Times New Roman">I<m>nformation<v> within this<c> email con<c>tains "fo<n>rward loo<n>king
statements"<k> within t<v>he meaning <w>o<r>f Section 27A of th<c>e Securi<f>ties A<l>ct of 1933 and <g>
Section 2<w>1B o<j>f the Sec<r>urities Ex<h>change Act o<d>f 1934. Any <e>statem<k>ents that e<f>xpress
or i<t>nvol<t>ve discussions <f>with respe<k>ct to predic<w>tions, g<t>oals, expectat<l>ions,
<f>belie<n>fs, plans, <c>projections,<j> objec<t>tives, assu<c>mptions or fu<n>ture events o<c>r
<m>
performance are<c> not stat<e>ements <e>of histo<e>rical fact and m<w>ay be "for<f>ward<r> looking
state<j>ments<w>.&#8221; Please b<r>e ad<l>vised that nothi<j>ng w<c>ithin this ema<j>il shall co<g>nstitu<o>te a
<t>solicitati<o>on or an of<x>fer to buy or sel<k>l any secu<w>rity menti<l>on<h>ed herein. Thi<h>s
n<g>ewsletter is n<r>either a reg<d>istered i<l>nvest<y>ment advisor n<h>or affiliate<w>d wit<w>h any
br<h>oker or d<r>ealer. This news<v>lette<m>r is not affili<m>ated with<j> In Vi<v>vo Medical
<k>
Diagnostic<l>s. This ne<j>wsletter<r> was produce<v>d and distr<y>ibuted b<t>y an independe<d>nt
<e>third party.<c> John Howar<y>d was compen<g>sated<l> 7500 do<x>llars to expres<v>s and<t> distribute<m>
his opin<h>ion through this <l>E-mail. Al<g>l<e> statements ma<k>de are our ex<d>press <t>opinion
only<v> and sho<l>uld be treated<c> <c>as such. W<n>e may own, buy a<l>nd sell a<f>ny secu<k>rities
menti<w>oned <k>at any ti<l>me. This repo<e>rt includes <j>forward<x>-looking <j>statements wi<x>thin
th<w>e meaning <x>of The Priva<n>te Securit<o>ies Litigat<w>ion Reform A<o>ct of 19<y>95. These
s<l>ta<t>tements ma<g>y include t<r>erms as "exp<c>ect", "<r>believe", <e>"may", "wi<x>ll",
"move<j>","underva<f>lued" and "inten<n>d" or <d>similar terms<g>. P<t>LEASE DO <c>YOUR OWN DUE
DILI<e>GENCE<r> BEFOR<m>E INVESTING <r>IN ANY PRO<l>FILED CO<k>MPANY. You m<c>ay lose money fro<h>m
inve<f>sting in <r>Penny Stocks.</FONT></P></FONT></DIV></BODY></HTML>

--Boundary_(ID_uUXxXAPFXR4CyNgSw1rjLA)--
